ADMA
ADMA Biologics, Inc. · Healthcare
Director Steve Elms sold $6.3M of ADMA Biologics, Inc.
Sold$6,339,418
$6.11Price
1,038,284Shares
−28%Stake
What ADMA did after the filing
- The stock from Mon, Mar 18 open, $6.03
- +8.1%
- S&P 500, same days
- −2.3%
Measured over 30 trading days, to the Apr 30 close.
Traded Wed, Mar 13. Filed Fri, Mar 15, 5:00 PM ET, after the close. Returns use the Mar 18 open and the Apr 30 close. Not investment advice.